Abdullahi Y. Abbas

Substituted 4-(Thiazol-5-yl)-2-(phenylamino)pyrimidines Are Highly Active CDK9 Inhibitors: Synthesis, X-ray Crystal Structures, Structure–Activity Relationship, and Anticancer Activities

Hao Shao, Shenhua Shi, Shi‐Liang Huang et al. · Journal of Medicinal Chemistry · 2013 · 124 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +16

Synthesis and biological evaluation of benzo[d]imidazole derivatives as potential anti-cancer agents

Hamad M. Alkahtani, Abdullahi Y. Abbas, Shudong Wang · Bioorganic & Medicinal Chemistry Letters · 2011 · 72 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +12

Targeting RNA transcription and translation in ovarian cancer cells with pharmacological inhibitor CDKI-73

Frankie Lam, Abdullahi Y. Abbas, Hao Shao et al. · Oncotarget · 2014 · 53 citations · Full text

Life Sciences, Molecular Biology, Oncology +14

Discovery of (<i>E</i>)-3-((Styrylsulfonyl)methyl)pyridine and (<i>E</i>)-2-((Styrylsulfonyl)methyl)pyridine Derivatives as Anticancer Agents: Synthesis, Structure–Activity Relationships, and Biological Activities

Tiangong Lu, Aik Wye Goh, Mingfeng Yu et al. · Journal of Medicinal Chemistry · 2014 · 38 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +13

Structure-based design of highly selective 2,4,5-trisubstituted pyrimidine CDK9 inhibitors as anti-cancer agents

Hao Shao, David Foley, Shi‐Liang Huang et al. · European Journal of Medicinal Chemistry · 2021 · 24 citations · Full text

Pharmacy, Medicinal Chemistry, Oncology +16